교수/연구실 소개

>대학소개 >교수/연구실 소개

전임교수

이 의 경Eui Kyung Lee

전공사회약학
사무실No. 530302
031-290-7786
연구실No. 530306
031-299-4378
e-mailekyung@skku.edu

이메일ekyung@skku.edu
홈페이지socialpharm.skku.edu
목록목록

학력/경력

최근 연구업적

Yang S-Y, Park S-K, Kang H-R, Kim H-L, Lee E-K, Kwon S-H. Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis. BMJ Supportive & Palliative Care. 2020:bmjspcare-2020-002453.
Yang S-Y, Do Jung H, Kwon S-H, Lee E-K, Lee JY, Lee S-H. Does Early Retrograde Intrarenal Surgery Improve the Cost-Effectiveness of Renal Stone Management? Yonsei Medical Journal. 2020;61(6):515.
Kim HL, Kim GA, Park JA, Kang HR, Lee EK, Lim YS. Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B. Gut. 2020.
Hong SH, Cho JY, Kim TB, Lee EK, Kwon SH, Shin JY. Cost-effectiveness of tiotropium in elderly patients with severe asthma using real-world data. J Allergy Clin Immunol Pract. 2020.
Song HJ, Park H, Park SY, Lee EK, Ha SY, Park SY, et al. Estimation of Health Utilities Based on the Response to Treatment in Atopic Dermatitis: a Population-based Study. Clin Ther. 2019;41(4):700-13.
Shin JY, Shin E, Jeong HE, Kim JH, Lee EK. Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia-Pacific region: Survey results from 15 countries. Pharmacoepidemiol Drug Saf. 2019;28(3):362-9.
Park SK, Nam JH, Lee H, Chung H, Lee EK, Shin JY. Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia. J Gastroen Hepatol. 2019;34(12):2135-43.
Park SK, Hong SH, Kim H, Kim S, Lee EK. Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea. Clin Ther. 2019;41(6):1066-79.
Lee H, Song I, Shin SM, Jeong HE, Lee EK, Shin JY. Regulatory effect of decreasing therapeutic duplication of respiratory drugs using a prescription database between 2012 and 2015. Regul Toxicol Pharmacol. 2019;103:218-28.
Kwon HY, Bae S, Choi SE, Park S, Lee EK, Park S, et al. Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. Health Policy. 2019;123(4):388-92.
Kim HL, An J, Park JA, Park SH, Lim YS, Lee EK. Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis. Hepatology. 2019;69(4):1599-613.
Kang HR, Lee EK, Kim WJ, Shin JY. Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study. J Antimicrob Chemother. 2019;74(2):453-61.
Kang HR, Hong SH, Ha SY, Kim TB, Lee EK. Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea. Respir Res. 2019;20(1):80.
Hong SH, Lee EK, Shin JY. Proton-pump inhibitors and the risk of Clostridium difficile-associated diarrhea in high-risk antibiotics users: A population-based case-crossover study. Pharmacoepidemiol Drug Saf. 2019;28(4):479-88.
Hong SH, Kang HR, Nam JH, Park SK, Kim TB, Lee EK. A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma. J Allergy Clin Immunol Pract. 2019;7(8):2642-52 e3.
Ha D, Song I, Park S, Lee EK. Factors Associated With the Management of Adverse Drug Reactions Among Community Pharmacists in South Korea. J Patient Saf. 2019;15(2):143-9.
Song I, Lee MS, Lee EK, Shin JY. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea. Asia Pac Psychiatry. 2018;10(1).
Song HJ, Lee EK. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey. Medicine (Baltimore). 2018;97(38):e12453.
Park SY, Jang EJ, Shin JY, Lee MY, Kim D, Lee EK. Prevalence and predictors of hypoglycemia in South Korea. Am J Manag Care. 2018;24(6):278-86.
Park KR, Kim KB, Baek YH, Sung HG, Park JT, Lee EK, et al. Signal detection of benzodiazepine use and risk of dementia: sequence symmetry analysis using South Korean national healthcare database. Int J Clin Pharm. 2018;40(6):1568-76.
Lee MY, Shin JY, Park SY, Kim D, Cha HS, Lee EK. Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: An analysis of the South Korean National Health Insurance Database. Semin Arthritis Rheum. 2018;47(4):485-91.
Kim J, Ha D, Song I, Park H, Lee SW, Lee EK, et al. Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real-world evidence using a nationwide database. Int J Rheum Dis. 2018;21(6):1227-36.
Hwang JE, Song I, Lee EK, Ha D, Shin JY. Prevalence and predictors of tricyclic antidepressant use among elderly Koreans in primary-care and specialty clinics. Int J Clin Pharmacol Ther. 2018;56(5):224-30.
Ha D, Song I, Lee EK, Shin JY. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012. BMC Health Serv Res. 2018;18(1):327.
Ha D, Lee J, Kim D, Oh IS, Lee EK, Shin JY. Healthcare utilization and medical expenditure of Korean psoriasis patients: A descriptive result using a health insurance database. Medicine (Baltimore). 2018;97(24):e11070.
Kang HJ, Park H, Oh JM, Lee EK. Perception of reporting medication errors including near-misses among Korean hospital pharmacists. Medicine (Baltimore). 2017;96(39):e7795.
Lee YM, Song I, Lee EK, Shin JY. Comparison of first- and second-generation antihistamine prescribing in elderly outpatients: A health insurance database study in 2013. Int J Clin Pharmacol Ther. 2017;55(10):781-90.
Kim JA, Kim ES, Lee EK. Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea. Medicine (Baltimore). 2017;96(14):e6577.
Lee YJ, Kwon SH, Hong SH, Nam JH, Song HJ, Lee JS, Lee EK, Shin JY. Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database. Clin Ther. 2017 Mar;39(3):527-536.
Park SK, Lee MY, Jang EJ, Kim HL, Ha DM, Lee EK. A comparison of discontinuation rates of tofacitinib and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis. Clin Exp Rheumatol. 2017 Jul-Aug;35(4):689-699. Epub 2017
Song I, Lee MS, Lee EK, Shin JY. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea. Asia Pac Psychiatry. 2017 Jun 20. doi: 10.1111/appy.12289. [Epub ahead of print]
Kwon SH, Park SK, Byun JH, Lee EK. Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea. Expert review of pharmacoeconomics & outcomes research. 2017 Jan 3:1-9.
Kim ES, Kim JA, Lee EK. National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007-2016 in South Korea. Expert review of pharmacoeconomics & outcomes research. 2017:1-9.
Heo JH, Rascati KL, Lee EK. Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. Value in Health Regional Issues. 2017;12:7-19.
Chin HJ, Nam JH, Lee EK, Shin JY, Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study,Medicine, accepted 18, May, 2017
Park SY, Park EJ, Suh HS, Ha DM, Lee EK, Development of a transformation model to derive general population–based utility: Mapping the pruritus–visual analog scale (VAS) to the EQ?5D utility, Journal of Evaluation in Clinical Practice, 2016 (accepted)
Song HJ, Lee EK, Kwon JW. Gender Differences in the Impact of Obesity on Health-Related Quality of Life. Asia-Pacific journal of public health. 2016;28(2):146-156.
Park SY, Oh SH, Kim J, Lee EK, et al. Single-Tooth Implant Versus Three-Unit Fixed Partial Denture: A Study of Oral Health-Related Quality of Life. The International journal of oral & maxillofacial implants. 2016;31(2):376-381.
Park SY, Han E, Kim J, Lee EK. Factors influencing the difference between forecasted and actual drug sales volumes under the price-volume agreement in South Korea. Health policy. 2016;120(8):867-874.
Park SK, Park SH, Lee MY, Park JH, Jeong JH, Lee EK. Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea. Clinical therapeutics. 2016;38(11):2430-2446.e2433.
Ku H, Lee EK, Lee KU, Lee MY, Kwon JW. Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study. Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists. 2016;8(2):145-153.
Kim TH, Lee EK, Han E. Incremental impact of body mass status with modifiable unhealthy lifestyle behaviors on pharmaceutical expenditure. Res Social Adm Pharm. 2016;12(6):990-1003.
Kim HL, Kim D, Jang EJ, Lee EK, et al. Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry data. Rheumatol Int. 2016;36(4):505-513.
Kim G, Lee YH, Han MH, Lee EK, et al. Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea. PloS one. 2016;11(3):e0151282.
Kim DK, Song HJ, Lee EK, Kwon JW. Effect of sex and age on the association between suicidal behaviour and obesity in Korean adults: a cross-sectional nationwide study. BMJ open. 2016;6(6):e010183.
Han E, Park SY, Lee EK. Assessment of the Price-Volume Agreement Program in South Korea. Health policy. 2016;120(10):1209-1215.
Byun JH, Park JA, Kang HR, Shin JY, Lee EK. Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study. Clin Drug Investig. 2016;36(11):957-968.
Byun JH, Kwon SH, Lee JE, Cheon JE, Jang EJ, Lee EK. Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments. Patient preference and adherence. 2016;10:641-650.
Byun JH, Kwon SH, Ha JH, Lee EK. A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients. Ther Clin Risk Manag. 2016;12:965-974.
Yang JH, Kim M, Park YT, Lee EK, Jung CY, Kim S. The effect of the introduction of a nationwide DUR system where local DUR systems are operating--The Korean experience. International journal of medical informatics. 2015;84(11):912-919.
Song HJ, Lee JA, Han E, Lee EK. Lifetime effectiveness of mifamurtide addition to chemotherapy in nonmetastatic and metastatic osteosarcoma: a Markov process model analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(9):6773-6779.
Lee MY, Park SK, Park SY, Lee EK, et al. Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea. Clinical therapeutics. 2015;37(8):1662-1676.e1662.
Ku H, Park S, Lee S, Lee EK, et al. Use of injectable drugs with oral-formulation alternatives for outpatients in South Korea. Archives of pharmacal research. 2015;38(7):1406-1413.
Kim T, Han N, Sohn M, Lee EK, et al. Pharmacogenomic biomarker information in FDA-approved paediatric drug labels. Basic Clin Pharmacol Toxicol. 2015;116(5):438-444.
Joo YB, Sung YK, Shim JS, Lee EK, et al. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study. Rheumatol Int. 2015;35(5):879-886.
Ha D, Song I, Park S, Lee EK. Factors Associated With the Management of Adverse Drug Reactions Among Community Pharmacists in South Korea. Journal of patient safety. 2015.
Cho SY, Lee DG, Choi JK, Lee EK, et al. Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis. Clinical therapeutics. 2015;37(9):2019-2027.
Eun-Ja Park, Hyun Soon Sohn, Eui-Kyung Lee, Jin-Won Kwon. Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse. BMC Public Health 2014, 14:1284, doi: 10.1186/1471-2458-14-1284.
Myeong Gyu Kim, Nayoung Han, Eui-Kyung Lee, Therasa Kim. Pegfilgrastim versus filgrastim in peripheral blood stem cell mobilization for autologous hematopoietic stem cell transplantation: A systematic review and meta-analysis. Bone Marrow Transplantation, 2015 Jan 12, doi:10.1038/bmt.2014.297.
Therasa Kim, Nayoung Han, Minji Sohn, Jung Mi Oh, Eui-Kyung Lee, Eunhee Ji and In-Wha Kim. Pharmacogenomic Biomarker Information in FDA-approved Paediatric Drug Labels. Basic & clinical pharmacology & toxicology 2014, Doi: 10.1111/bcpt.12341.
Min-Jeoung Kang, Chai Young Jung, Soyoun Kim, Yookyung Boo, Yuri Lee, Sundo Kim, Yeonmi Choi, Eui-Kyung Lee and Sukil Kim. Stakeholder analysis for adopting a personal health record standard in Korea. Health Information Management Journal 2014, http://dx.doi.org/10.12826/18333575.2014.0016.Kim.
Choi, Young-Euna, Ha, Hyung-Serkb, Lim, Jae-Younga*, Lee, Eui-Kyung. Revisit the effect of the prenatal medical care use on the birth outcome of newborn baby. Hitotsubashi Journal of Economics, 2014 Oct 8.
Young Bin Joo, Yoon-Kyoung Sung, Jee-Seon Shim, Jae-Hoon Kim, Eui-Kyung Lee, Hye-Soon Lee, Sang-Cheol Bae. Prevalence, incidence, andassociated factors of avascular necrosis in Korean patients with systemiclupus erythematosus: a nationwide epidemiologic study. Rheumatology International, 2014 Oct 10, DOI 10.1007/s00296-014-3147-3.
Min-Young Lee, MS; Hee-Jin Kang, MS; Se-Young Park, MS; Hye-Lin Kim, MS; Euna Han, PhD; and Eui-Kyung Lee, PhD. Cost-Effectiveness of Tolvaptan for Euvolemic or Hypervolemic Hyponatremia. Clinical Therapeutics 2014; Vol 36, No. 9: 1183-1194.
Eun-Ja Park, PhD, Jin-Won Kwon, PhD, Eui-Kyung Lee, PhD, Young-Ho Jung, PhD, Sylvia Park, PhD. Out-of-pocket medication expenditure burden of elderly Koreans with chronic conditions. International Journal of Gerontology, 2014 Jun 24.
Hyun Jin Song, Eui-Kyung Lee, Jun Ah Lee, Hye-Lin Kim, Kyoung Won Jang. The Addition of Mifamurtide to Chemotherapy Improves Lifetime Effectiveness in Children with Osteosarcoma: A Markov Model Analysis. Tumor Biology 2014; 35: 8771-8779. DOI: 10.1007/s13277-014-2139-y.
Hee-Jin Kang, Eunjeong Kang, Min-Woo Jo, Eun-Ja Park, Seonyoung Yoon, Eui-Kyung Lee. The Utility Score of Epilepsy with Partial Seizure Measured by TTO, VAS, and EQ-5D in the General Korean Population. Epilepsy research 2014; Vol 108, No. 5: 963-971.
Y. Choi, C. Jung, Y. Chae, M. Kang, J. Kim, K. Joung, J. Lim, S. Cho, S. Sung, E. Lee, S. Kim. Comparison of Validity of Mapping between Drug Indications and ICD-10. METHODS OF INFORMATION IN MEDICINE 2014; Vol 53, No. 3: 195-201
Hye-Lin Kim, Min-Young Lee, Sun-Young Park, Sun-Kyeong Park, Ji-Hye Byun, Sunhong Kwon, Eui-Kyung Lee. Comparative Effectiveness of Cycling of Tumor Necrosis Factor-α (TNF-α) Inhibitors versus Switching to Non-TNF Biologics in Rheumatoid Arthritis Patients with Inadequate Response to TNF-α Inhibitor Using a Bayesian Approach. Archives of Pharmacal Research 2014; 37: 662-670.
Tae Hyun Kim Ph.D., Eui-Kyung Lee Ph.D., Euna Han Ph.D.. Food away from home and body mass outcomes: Taking eterogeneity into account enhances quality of results. Nutrition 2014; Vol 30: 1015-1021.
Iyn-Hyang Lee, Sylvia Park and Eui-Kyung Lee. Socio-demographic factors influencing the use of injections in South Korean outpatient care. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2014; Vol 23, No. 1: 51-59. DOI: 10.1002/pds.3376.
Lloyd Davis, M.D., Luigi Brunetti, Pharm.D., M.P.H., Eui-Kyung Lee, Ph.D., Nari Yoon, B.S., Sung-Hee Cho, B.S, Dong-Churl Suh, Ph.D.. Effects of computerized physician order entry on Medication Turnaround Time and Orders Requiring Pharmacist Intervention. Research in Social and Administrative Pharmacy 2014; Vol 10, No. 5: 756-767.
Soo-Kyung Cho, Yoon-Kyoung Sung, Chan-Bum Choi, Jeong-Mi Kwon, Eui-Kyung Lee, Sang-Cheol Bae. Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database. RHEUMATOLOGY INTERNATIONAL 2013; 33: 2985-2992. DOI 10.1007/s00296-013-2833-x.
Euna Han, PhD; Tae Hyun Kim, PhD; Myung Jin Jeung, PhD; and Eui-Kyung Lee, PhD. Analyses of Direct and Indirect Impacts of a Positive List System on Pharmaceutical R&D Investments. Clinical Therapeutics 2013; Vol 35, No. 7: 941-949.
Ji Haeng Heo, Dong Churl Suh, Sukil Kim, Eui-Kyung Lee. Evaluation of the pilot program on the real-time drug utilization review system in South Korea. INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS 2013; Vol 82: 987-995.
Mihae Park, Changik Jo, Eun Young Bae, Eui-Kyung Lee, A Comparison of Preferences of Targeted Therapy for Metastatic Renal Cell Carcinoma between the patient group and medical expert group, Value in Health 2012; Vol 15, No. 6: 933-939.
Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, Park SJ, Park YS, Shin SJ, Lee MA, Lee NS, Zang DY, Bae EJ, Kang MJ, Clinical and Cost Effectiveness of Bevacizumab plus FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea, Clinical Therapeutics 2012; Vol 34, No. 6: 1408-1419.
Lee EK, Kim BY, Lim JY, Park MH. Different Policy Outcomes of the New Drugs and Currently-Listed Drugs under the Positive List System in South Korea. Value in Health 2012; Vol 15, s100-s103.
Lim MK, Bae EY, Choi SE, Lee EK, Lee TJ. Eliciting Public Preference for Health Care Resource Allocation in South Korea. Value in Health 2012; Vol 15, s91-s94.
Mo YH, Rhee J, Lee EK. Nutrition Support Team Services in the Intensive Care Unit of a General Hospital in South Korea. YAKUGAKU ZASSHI 2011, Vol 131, 1827-1833.
Kwon JM, Cho SK, Kim JH, Lee EK. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database. Rheumatology International, 2012; Vol 32, No. 9: 2893-2899.
Ha DM, Choi Y, Kim DU, Jeong GH, Lee EK. A Comparative Analysis of the Impact of a Positive List System between New Chemical Entity Drugs versus Incrementally Modified Drugs in South Korea. Clinical Therapeutics 2011; Vol 33, No.7: 926-932.
Bae EY, Lee EK. Pharmacoeconomic Guidelines and Their Implementation in the Positive List System in South Korea. Value in Health 2009; 12, Supplement 3, Nov/Dec: S36-S41.
Bae JY, Kim CH, Lee EK. Evaluation of Cost-Utility of Varenicline Compared with Existing Smoking Cessation Therapies in South Korea. Value in Health 2009; 12, Supplement 3, Nov/Dec: S70-S73.
Lee EK and Malone DC. Comparison of Peptic-Ulcer Drug Use and Expenditures Before and After the Implementation of a Government Policy to Separate Prescribing and Dispensing Practices in South Korea. Clinical Therapeutics 2003; 25( 2): 578-592.
Kim HL, Rhee J, Lee EK. Factors Associated with the Price of Pharmaceuticals Purchased through Open Competitive Bidding System of a Public General Hospital in South Korea. The Korean Journal of Health Economics and Policy 2011, Vol.17, No.2, 77~97.
Jang HM, Lee EK. Impact and barriers of the health insurance review on splitting extended-release formulation drugs, Kor.J.Clin.Pharm., 2011, Vol. 21, No. 4., 347~352.
Park MH, Rhee J, Lee EK. Comparative analysis of the seriousness of the adverse events and risk of targeted therapy for metastatic renal cell carcinoma among medical professionals. Kor.J.Clin.Pharm., 2011, Vol. 21, No. 2., 100~105.
Rhee J, Park SY, Heo JH, Park MH, Ha JH, Lee EK. Measuring the seriousness of adverse drug reactions: Comparisons between Korean experts and WHO working group members, Kor.J.Clin.Pharm., 2011, Vol. 21, No. 3., 237~242.
Park JY, Ahn JH, Suh HS, Park SY, Hyun MK, Sung YK, Lee EK, Kim YH. Willingness to pay for treatment for osteoporotic fracture risk reduction, The Korean Journal of Health Economics and Policy, 2011, Vol.17, No.3, 23~50.
Kang SH, Song HJ, Heo JH, Lee EK. Pharmacoeconomic analysis of Tafluprost compared with Latanoprost on the treatment of primary open angle glaucoma or ocular hypertension in Korea. The Korean Journal of Health Economics and Policy, 2010, Vol.20, No.3, 278~287.
Ku HM, Kim JY, Kang SH, Lee EK. Meta-analysis of Inline Filtration Effects on Post-infusion Phlebitis Caused by Particulate Contamination of Intravenous Administration. Journal of Pharmaceutical Investigation 2010, Vol. 40, No. 4, 225-230.
Ha DM, Lee SK, Kim DU, Chung KH, Lee EK. A Comparative Analysis of Perception of Health Professionals and Pharmaceutical Companies on the Positive List System. Yakhak Hoeji 2010; 54(4): 309-315
LEE JH, Lee EK. Comparison of Chronic Myeloid Leukemia Patient’s Utility Weights. Korean Journal of Clinical Pharmacy 2009; 19(2): 153-158.
Ku HM, Kwon JM, Park SY, Kang SH, Lee EK. A Case Study using Transferability Diagnosis Tools Between Countries for Economic Evaluations of Rheumatoid Arthritis Drugs. Korean Journal of Clinical Pharmacy 2009; 19(2): 81-88.
LEE JK, Lee EK. Effects of Pioglitazone and Rosiglitazone on glucose and the cardiovascular risk factors in patients with type 2 diabetes: a meta-analysis. Yakhak Hoeji 2009; 53(6).
Lee EK, Ko SK, Bae SC, Sung YK. Cost-effectiveness of early use of etanercept in the treatment of rheumatoid arthritis. Journal of Korean Society for Clinical Pharmacology and Therapeutics 2009; 17(1): 93-106.
Ko MJ, Hong SH, Lee JH, Oh YB, Lee YJ, Song HJ, Lee EK. Analysis of Master's and Doctoral Theses on Social Pharmacy Field in Korea, Yakhak Hoeji 2009; 53(4): 173-178.
Hur JH, Jung KH, Lee EK. A Meta-Analysis of Utility Weights for Stroke. Yakhak Hoeji 2009; 53(5): 265-273.
Kang HJ, Lee EK. A Study on Willingness to Pay for Medication Therapy Management Service of Polypharmacy Patients. Journal of Korean Academy of Managed Care Pharmacy 2009; 1(1): 33-37.

수행과제

수출국 대상 허가심사 규제정보 개발 연구 (식품의약품안전평가원)
의약품 등 안전관리를 위한 기획연구 (식품의약품안전평가원)
국내 개발 임상시험의 구조분석 및 시사점 (임상시험사업본부)
만성 B형간염 환자에서 항바이러스 약물요법의 비용효과 분석 (서울아산병원/한국보건의료연구원)
APEC 국가대상 약물감시 규제조화 실행방안 연구 (식품의약품안전평가원)
해외 의약품 허가체계 연구 - 러시아, 중국 등 (식품의약품안전평가원)
제약산업 인력 수급체계 및 전문인력 양성 방안 연구 (한국보건산업진흥원)
주요 수출국 의약품 허가체계 제공을 통한 수출지원 연구 - 동남아시아, 중남미 국가 등 (식품의약품안전평가원)
임상시험산업 경쟁력강화를 위한 임상시험비용 건강보험 적용방안 연구 (한국임상시험산업본부)
의약품 보험 등재 의사결정을 위한 MCDA 활용방안 연구 (한국다국적의약산업협회)
APEC 국가 대상 약물감시, 부작용관리 교육 프로그램 개발 (식품의약품안전처)
의약품 유익성-위해성 균형 평가 모델 최적화 연구(II) - 근골격계 작용 약물 대상 (식품의약품안전평가원)
약가 및 보험등재 현황 국제 비교 연구 (한국다국적의약산업협회)
약국 진료비 예측가능성을 확보할 수 있는 실행모형 공동연구 (국민건강보험공단)
약가결정에서의 예상사용량 예측도 제고방안 연구 (국민건강보험공단)
의약품 유익성-위해성 균형 평가 모델 최적화 연구(I) - 심혈관계용약대상 (식품의약품안전평가원)
한국형 의약품 유익성/위해성 균형 평가 모델에 필요한 평가 요소 및 가중치 설정을 위한 설문지 개발 (식품의약품안전평가원)
적정기준가격제 시행방안 연구 (건강보험심사평가원)
의약품 리스크관리 및 평가를 위한 세부실행방안연구 (식품의약품안전청)
신약개발 RND촉진과 각국의 약가정책연구방안 (한국보건산업진흥원)
의약품 안전관리 선진화 및 제약산업 경쟁력 강화를 위한 중단기 전략개발 연구 (식품의약품안전청)
2단계 의약품 처방조제지원시스템 시범사업 평가연구 (건강보험심사평가원)

연구부문

Pharmacoeconomics: anti-cancer, rheumatoid arthritis drugs etc.
Pharmaceutical pricing and reimbursement policy
Drug approval and safety control policy
Pharmaceutical outcomes research

성균관대학교 약학대학

skku school of pharmacy

교수/연구실 소개

이 의 경Eui Kyung Lee

학력

주요경력

최근 연구업적

수행과제

연구부문